Fires in the Amazon: a barrier to climate change up in smoke
SAO PAULO (Reuters) - Fire is not natural in the Amazon. Virgin rainforest, no matter how fierce the sun, is too wet to catch alight. If the forest burns it is almost always because of humans.
WIDER IMAGE-Fires in the Amazon: a barrier to climate change up in smoke
SAO PAULO, Dec 6 (Reuters) - Fire is not natural in the Amazon. Virgin rainforest, no matter how fierce the sun, is too wet to catch alight. If the forest burns it is almost always because of humans.
Trading carbon credits from nature sparks fiery debate at UN talks
MADRID, Dec 5 (Thomson Reuters Foundation) - Oil and gas companies have teamed up with the International Emissions Trading Association (IETA) on a new effort to build a global market for carbon credits generated from projects to conserve forests, soil and wetlands, they said on Thursday.
Emotion-sensing robot launches to assist space station astronauts
WASHINGTON (Reuters) - An intelligent robot equipped with emotion-sensing voice detectors was headed to the International Space Station after launching from Florida on Thursday, becoming the latest artificial intelligence-powered astronaut workmate in orbit.
Tiny AI devices aim to enrich farmers and their soil
ROME, Dec 5 (Thomson Reuters Foundation) - A piece of paper no bigger than a business card could enrich struggling coffee farmers and their soil, a growing challenge as temperatures rise and prices fluctuate.
'Cranky Uncle' game offers a vaccination against climate disinformation
LONDON, Dec 5 (Thomson Reuters Foundation) - When it comes to climate change, deciding what facts you can trust and what's fake news can be a challenge, particularly in an era of sophisticated misinformation campaigns and complex scientific data.
New Biogen data showed no major safety issues for its Alzheimer's drug
SAN DIEGO/CHICAGO (Reuters) - Biogen Inc on Thursday presented new data on its experimental Alzheimer's drug aducanumab that eased concerns raised by some experts but still left many questions unanswered as the company made its case about why it plans to seek U.S. approval after declaring the drug a failure in March.
WHO decries "collective failure" as measles kills 140,000
LONDON, Dec 5 (Reuters) - Measles infected nearly 10 million people in 2018 and killed 140,000, mostly children, as devastating outbreaks of the viral disease hit every region of the world, the World Health Organization said on Thursday.
Novartis R&D boss says doesn't see big opportunity in oral SMA therapy
ZURICH (Reuters) - Novartis research head Jay Bradner said on Thursday the Swiss drugmaker is focusing efforts against spinal muscular atrophy (SMA) on gene therapy Zolgensma and retreating from oral therapy like its molecule LMI070, also called branaplam.
Half a million Ebola vaccine doses to be stockpiled for emergency use
LONDON, Dec 5 (Reuters) - - A stockpile of 500,000 doses of Ebola vaccine for emergency use in outbreaks of the deadly fever is being established by the global vaccine alliance GAVI.
- More Science Headlines»